Century Therapeutics Inc. (NASDAQ: IPSC) Stock Information | RedChip

Century Therapeutics Inc. (NASDAQ: IPSC)


$1.0550
-0.0450 ( -4.96% ) 288.3K

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Market Data


Open


$1.0550

Previous close


$1.1000

Volume


288.3K

Market cap


$88.43M

Day range


$1.0250 - $1.1800

52 week range


$0.9800 - $5.5100

SEC Filings


Form Type Description Pages Date
4 Insider transactions 2 Mar 11, 2024
4 Insider transactions 2 Mar 11, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Feb 21, 2024
4 Insider transactions 1 Feb 07, 2024
4 Insider transactions 1 Feb 07, 2024
8-k 8K-related 12 Jan 19, 2024
8-k 8K-related 47 Dec 11, 2023
4 Insider transactions 1 Dec 06, 2023
8-k 8K-related 14 Dec 06, 2023

Latest News